Harmony Biosciences Holdings IncNASDAQ:HRMY
- LAST PRICE29.0300
- TODAY'S CHANGE (%)-0.2800 (-0.9553%)
- Bid / Lots26.9000/ 1
- Ask / Lots34.0400/ 1
- Open / Previous Close29.3000 / 29.3100
- Day Range
- 52 Week Range
- Volume334,571
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | HRMY |
|---|---|---|
| 09:32 ET | 13351 | 29.18 |
| 09:34 ET | 4507 | 29.1804 |
| 09:36 ET | 600 | 29.075 |
| 09:38 ET | 100 | 29.23 |
| 09:39 ET | 100 | 28.95 |
| 09:41 ET | 300 | 28.88 |
| 09:43 ET | 201 | 28.911 |
| 09:45 ET | 5400 | 29.11 |
| 09:48 ET | 303 | 28.8701 |
| 09:50 ET | 100 | 28.98 |
| 09:52 ET | 787 | 28.99 |
| 09:54 ET | 1300 | 29.08 |
| 09:56 ET | 478 | 29.27 |
| 09:57 ET | 100 | 29.205 |
| 09:59 ET | 200 | 29.09 |
| 10:01 ET | 1450 | 29.36 |
| 10:03 ET | 6800 | 29.39 |
| 10:06 ET | 300 | 29.37 |
| 10:10 ET | 100 | 29.36 |
| 10:12 ET | 100 | 29.28 |
| 10:14 ET | 100 | 29.39 |
| 10:15 ET | 200 | 29.4 |
| 10:17 ET | 500 | 29.38 |
| 10:19 ET | 415 | 29.4498 |
| 10:21 ET | 5500 | 29.37 |
| 10:24 ET | 501 | 29.37 |
| 10:30 ET | 2792 | 29.46 |
| 10:32 ET | 303 | 29.4 |
| 10:33 ET | 9691 | 29.2 |
| 10:35 ET | 1191 | 29.14 |
| 10:42 ET | 100 | 29.15 |
| 10:46 ET | 300 | 29.15 |
| 10:48 ET | 400 | 29.13 |
| 10:50 ET | 100 | 29.115 |
| 10:51 ET | 216 | 29.1138 |
| 10:53 ET | 968 | 29.05 |
| 10:55 ET | 600 | 29.02 |
| 10:57 ET | 1854 | 28.995 |
| 11:00 ET | 200 | 29.03 |
| 11:02 ET | 405 | 29.08 |
| 11:06 ET | 1000 | 29.185 |
| 11:08 ET | 475 | 29.1616 |
| 11:09 ET | 100 | 29.16 |
| 11:11 ET | 900 | 29.15 |
| 11:13 ET | 1234 | 29.14 |
| 11:18 ET | 200 | 29.14 |
| 11:20 ET | 309 | 29.14 |
| 11:22 ET | 2281 | 29.055 |
| 11:24 ET | 200 | 29.08 |
| 11:26 ET | 400 | 29.09 |
| 11:29 ET | 101 | 29.085 |
| 11:33 ET | 100 | 29.085 |
| 11:38 ET | 1284 | 29.0525 |
| 11:40 ET | 300 | 29.07 |
| 11:42 ET | 1700 | 29.02 |
| 11:44 ET | 400 | 29.01 |
| 11:45 ET | 100 | 28.97 |
| 11:47 ET | 1412 | 29.055 |
| 11:49 ET | 100 | 29.025 |
| 11:51 ET | 200 | 29.08 |
| 11:56 ET | 144 | 29.06 |
| 11:58 ET | 100 | 29.035 |
| 12:00 ET | 100 | 29.035 |
| 12:02 ET | 200 | 29.035 |
| 12:05 ET | 200 | 29.035 |
| 12:07 ET | 100 | 29.035 |
| 12:14 ET | 1603 | 29.14 |
| 12:18 ET | 100 | 29.24 |
| 12:20 ET | 600 | 29.245 |
| 12:23 ET | 904 | 29.25 |
| 12:25 ET | 2100 | 29.345 |
| 12:27 ET | 1900 | 29.19 |
| 12:30 ET | 200 | 29.225 |
| 12:32 ET | 202 | 29.2 |
| 12:34 ET | 390 | 29.205 |
| 12:36 ET | 200 | 29.205 |
| 12:38 ET | 100 | 29.205 |
| 12:39 ET | 200 | 29.2 |
| 12:41 ET | 500 | 29.3 |
| 12:43 ET | 200 | 29.26 |
| 12:45 ET | 838 | 29.3 |
| 12:48 ET | 800 | 29.22 |
| 12:50 ET | 600 | 29.24 |
| 12:52 ET | 200 | 29.235 |
| 12:54 ET | 706 | 29.26 |
| 12:57 ET | 600 | 29.27 |
| 12:59 ET | 500 | 29.245 |
| 01:01 ET | 100 | 29.265 |
| 01:06 ET | 100 | 29.235 |
| 01:08 ET | 200 | 29.24 |
| 01:10 ET | 100 | 29.26 |
| 01:12 ET | 600 | 29.25 |
| 01:15 ET | 617 | 29.325 |
| 01:17 ET | 1050 | 29.35 |
| 01:19 ET | 9500 | 29.35 |
| 01:21 ET | 400 | 29.48 |
| 01:24 ET | 200 | 29.5 |
| 01:26 ET | 100 | 29.53 |
| 01:28 ET | 445 | 29.52 |
| 01:30 ET | 600 | 29.49 |
| 01:32 ET | 2800 | 29.34 |
| 01:33 ET | 100 | 29.355 |
| 01:37 ET | 605 | 29.315 |
| 01:42 ET | 550 | 29.31 |
| 01:44 ET | 895 | 29.32 |
| 01:48 ET | 801 | 29.415 |
| 01:50 ET | 100 | 29.44 |
| 01:51 ET | 750 | 29.4025 |
| 01:55 ET | 622 | 29.4 |
| 01:57 ET | 200 | 29.42 |
| 02:00 ET | 100 | 29.44 |
| 02:02 ET | 1000 | 29.42 |
| 02:04 ET | 1800 | 29.475 |
| 02:06 ET | 717 | 29.44 |
| 02:08 ET | 300 | 29.35 |
| 02:09 ET | 300 | 29.37 |
| 02:13 ET | 200 | 29.4 |
| 02:15 ET | 300 | 29.37 |
| 02:20 ET | 300 | 29.345 |
| 02:22 ET | 200 | 29.36 |
| 02:24 ET | 400 | 29.34 |
| 02:26 ET | 500 | 29.31 |
| 02:27 ET | 471 | 29.3 |
| 02:29 ET | 300 | 29.26 |
| 02:31 ET | 100 | 29.3 |
| 02:33 ET | 900 | 29.375 |
| 02:36 ET | 100 | 29.375 |
| 02:38 ET | 900 | 29.38 |
| 02:40 ET | 10917 | 29.36 |
| 02:44 ET | 100 | 29.28 |
| 02:45 ET | 300 | 29.29 |
| 02:47 ET | 700 | 29.3 |
| 02:49 ET | 400 | 29.3 |
| 02:51 ET | 1060 | 29.305 |
| 02:54 ET | 200 | 29.365 |
| 02:56 ET | 600 | 29.385 |
| 02:58 ET | 2070 | 29.21 |
| 03:00 ET | 200 | 29.185 |
| 03:02 ET | 600 | 29.17 |
| 03:03 ET | 409 | 29.14 |
| 03:05 ET | 600 | 29.14 |
| 03:07 ET | 200 | 29.11 |
| 03:09 ET | 1415 | 29.21 |
| 03:12 ET | 100 | 29.26 |
| 03:14 ET | 200 | 29.255 |
| 03:16 ET | 800 | 29.24 |
| 03:18 ET | 1293 | 29.22 |
| 03:20 ET | 300 | 29.17 |
| 03:21 ET | 300 | 29.2 |
| 03:23 ET | 700 | 29.24 |
| 03:27 ET | 400 | 29.22 |
| 03:30 ET | 1335 | 29.26 |
| 03:32 ET | 1470 | 29.29 |
| 03:34 ET | 3322 | 29.19 |
| 03:36 ET | 300 | 29.18 |
| 03:38 ET | 1100 | 29.175 |
| 03:39 ET | 500 | 29.11 |
| 03:41 ET | 1301 | 29.09 |
| 03:43 ET | 600 | 29.0675 |
| 03:45 ET | 1300 | 29.04 |
| 03:48 ET | 2600 | 29.09 |
| 03:50 ET | 1300 | 29.03 |
| 03:52 ET | 3137 | 29.12 |
| 03:54 ET | 3408 | 29.07 |
| 03:56 ET | 6300 | 29.185 |
| 03:57 ET | 12226 | 29.1 |
| 03:59 ET | 8198 | 29.03 |
May 1, 2024
DJ Harmony Biosciences Is Maintained at Buy by Needham, from 5:45AM ET on Wednesday May 01, 2024 by Dow Jones
5:45AM ET on Wednesday May 01, 2024 by Dow Jones
Apr 30, 2024
DJ Harmony Biosciences Shares Rise After Earnings, Acquisition, from 11:29AM ET on Tuesday Apr 30, 2024 by Dow Jones
11:29AM ET on Tuesday Apr 30, 2024 by Dow JonesDJ Harmony Biosciences Price Target Maintained With a $50.00/Share by Needham, from 8:27AM ET on Tuesday Apr 30, 2024 by Dow Jones
8:27AM ET on Tuesday Apr 30, 2024 by Dow JonesDJ Harmony Biosciences Buys Epygenix Therapeutics For Initial $35 Million, from 7:40AM ET on Tuesday Apr 30, 2024 by Dow Jones
7:40AM ET on Tuesday Apr 30, 2024 by Dow JonesHarmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy, from 7:05AM ET on Tuesday Apr 30, 2024 by Dow Jones
7:05AM ET on Tuesday Apr 30, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Harmony Biosciences Holdings Inc | 1.7B | 12.5x | --- |
Taro Pharmaceutical Industries Ltd | 1.6B | 34.8x | -33.66% |
Tilray Brands Inc | 1.7B | -4.0x | --- |
Collegium Pharmaceutical Inc | 1.1B | 15.8x | --- |
Pacira Biosciences Inc | 1.5B | 23.8x | --- |
Amphastar Pharmaceuticals Inc | 2.1B | 15.0x | --- |
Company Information
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company. It is focused on developing and commercializing therapies for patients living with rare neurological diseases as well as patients living with other neurological diseases who have unmet medical needs. Its product, WAKIX (pitolisant), is a first-in-class molecule with a novel mechanism of action designed to enhance histamine signaling in the brain by binding to H3 receptors. Its WAKIX is developed for the treatment of excessive daytime sleepiness (EDS) in adult patients with narcolepsy and treatment of cataplexy in adult patients with narcolepsy. It also provides HBS-102, an investigational compound, which is a melanin-concentrating hormone receptor 1 (MCHR1) antagonist that targets MCH neurons in the brain. It also develops ZYN002, a pharmaceutically manufactured synthetic cannabidiol. It is also focused on the rare epilepsy franchise in its expanding late-stage pipeline of CNS assets: EPX-100 and EPX-200.
Contact Information
- Headquarters
- 630 W Germantown Pike, Suite 215PLYMOUTH MEETING, PA, United States 19462
- Phone
- 484-539-9800
- Fax
- 302-655-5049
Executives
- Non-Executive Chairman of the Board
- Jeffrey Aronin
- President, Chief Executive Officer, Director
- Jeffrey Dayno
- Chief Financial Officer, Chief Administrative Officer
- Sandip Kapadia
- Chief Scientific Officer
- Kumar Budur
- Chief Commercial Officer
- Jeffrey Dierks
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.6B |
|---|---|
Revenue (TTM) | $617.5M |
Shares Outstanding | 56.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.71 |
EPS | $2.32 |
Book Value | $8.23 |
P/E Ratio | 12.5x |
Price/Sales (TTM) | 2.7 |
Price/Cash Flow (TTM) | 10.2x |
Operating Margin | 31.40% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
